Ingalls & Snyder LLC Bristol Myers Squibb CO Call Options Transaction History

Ingalls & Snyder LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $609,346 - $690,880	12,700 New	12,700 $689,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $268,694 - $295,926	-3,700 Reduced 20.22%	14,600 $1.12 Million
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $1.13 Million - $1.23 Million	18,300 New	18,300 $1.22 Million

2,537

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.